NEW YORK, Oct. 22 (GenomeWeb News) – Large Scale Biology reported revenues of $1.2 million for the third quarter, compared to $0.7 million in the same period last year.
The Vacaville, Calif., company had a net loss of $4.3 million for the quarter, compared to $6.8 million for the third quarter of 2002.
LSBC's R&D expenses decreased to $2.8 million, from $4.5 million in the year-ago quarter.
At the end of the third quarter, the company had $11.3 million in cash and marketable securities.